NCT06457139 Preventing T2DM After GDM With Immediate Postpartum Screening
| NCT ID | NCT06457139 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Gestational Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 116 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2028-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 116 participants in total. It began in 2025-06-01 with a primary completion date of 2028-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.
Eligibility Criteria
Inclusion Criteria: * pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria * receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial * able and willing to provide informed consent * ability to complete immediate in hospital postpartum glucose testing * have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL Exclusion Criteria: * known diagnosis of pre-existing pre-gestational diabetes in pregnancy * inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum * systemic steroid use
Contact & Investigator
Gianna Wilkie, MD
PRINCIPAL INVESTIGATOR
UMASS Memorial Healthcare
Frequently Asked Questions
Who can join the NCT06457139 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06457139 currently recruiting?
Yes, NCT06457139 is actively recruiting participants. Contact the research team at Gianna.Wilkie@umassmemorial.org for enrollment information.
Where is the NCT06457139 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT06457139 clinical trial?
NCT06457139 is sponsored by University of Massachusetts, Worcester. The principal investigator is Gianna Wilkie, MD at UMASS Memorial Healthcare. The trial plans to enroll 116 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.